Lehrstuhl für Genetik

Inducing long-lasting HIV Env-specific antibody responses by intrastructural help Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention Oct. 1, 2019 - March 31, 2024 IMPACT OF a2,6-LINKED SIALIC ACID RESIDUES ON B CELL DEVELOPMENT AND ANTIBODY FUNCTION IN VIVO (TP 3) Sialinsäure als Regulator in Entwicklung und Immunität July 1, 2020 - June 30, 2023 Pathogenicity of IgA-type autoantibodies in pemphigoid disease June 1, 2020 - May 31, 2023 IgG glycosylation as a regulative factor controlling onset of RA (TP 06 / FOR2886) Aug. 1, 2019 - July 31, 2022 Projekt B2: Die IgG Glykosylierung in der Regulation der rheumatoiden Arthritis (TP 06) July 1, 2019 - June 30, 2022 Glykosylierung von IgG Subtypen Nov. 1, 2018 - Oct. 31, 2021 Integrative 'Big Data Modeling' for the development of novel therapeutic approaches for breast cancer (BIG-THERA) Jan. 1, 2017 - June 30, 2020 Cell Cycle in Disease and Regeneration - Towards an Integrative View on Cell Cycle Control and Terminal Differentiation: Implications for Disease and Regeneration (CYDER) Jan. 1, 2014 - Dec. 31, 2017 Understanding the role of the human inhibitory FcGamma-receptor for autoreactive and protective humoral immune responses in vivo (13) (TRR 130) TRR 130: B-Zellen: Immunität und Autoimmunität July 1, 2013 - July 1, 2016 Investigating the mechanism of antibody mediated effector functions in vivo (B14) (SFB 643) SFB 643: Strategien der zellulären Immunintervention Jan. 1, 2013 - Jan. 1, 2016